Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP435426.RA3beJvhQSjW_Aj1UpUzNf56vJhB2bO6ZJfEC4AENyP1E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP435426.RA3beJvhQSjW_Aj1UpUzNf56vJhB2bO6ZJfEC4AENyP1E130_assertion type Assertion NP435426.RA3beJvhQSjW_Aj1UpUzNf56vJhB2bO6ZJfEC4AENyP1E130_head.
- NP435426.RA3beJvhQSjW_Aj1UpUzNf56vJhB2bO6ZJfEC4AENyP1E130_assertion description "[Therefore, targeting invading cancer cells with the PEI-anti-MMP-2 antibody conjugate could be promising in endometrial cancer treatment, and this gene delivery system deserves further optimization in the context of targeted therapeutic gene delivery.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP435426.RA3beJvhQSjW_Aj1UpUzNf56vJhB2bO6ZJfEC4AENyP1E130_provenance.
- NP435426.RA3beJvhQSjW_Aj1UpUzNf56vJhB2bO6ZJfEC4AENyP1E130_assertion evidence source_evidence_literature NP435426.RA3beJvhQSjW_Aj1UpUzNf56vJhB2bO6ZJfEC4AENyP1E130_provenance.
- NP435426.RA3beJvhQSjW_Aj1UpUzNf56vJhB2bO6ZJfEC4AENyP1E130_assertion SIO_000772 18454694 NP435426.RA3beJvhQSjW_Aj1UpUzNf56vJhB2bO6ZJfEC4AENyP1E130_provenance.
- NP435426.RA3beJvhQSjW_Aj1UpUzNf56vJhB2bO6ZJfEC4AENyP1E130_assertion wasDerivedFrom befree-20140225 NP435426.RA3beJvhQSjW_Aj1UpUzNf56vJhB2bO6ZJfEC4AENyP1E130_provenance.
- NP435426.RA3beJvhQSjW_Aj1UpUzNf56vJhB2bO6ZJfEC4AENyP1E130_assertion wasGeneratedBy ECO_0000203 NP435426.RA3beJvhQSjW_Aj1UpUzNf56vJhB2bO6ZJfEC4AENyP1E130_provenance.